400 Collins Street
Level 6
Melbourne, VIC 3000
Australia
61 3 9068 1062
https://www.bio-gene.com.au
Sector(s): Healthcare
Industry: Biotechnology
Full-time employees:
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Mr. Roger McPherson B.Bus, C.P.A., CPA, GAICD | Interim CFO & Company Secretary | 139.58k | N/A | N/A |
Mr. Peter Donald May AFA1M, AFAIM, GAICD, M.B.A., MBA | Executive Director of Research & Development and Executive Director | 235.86k | N/A | N/A |
Mr. Timothy Owen Grogan B.Sc., LLB | MD, CEO & Director | N/A | N/A | N/A |
Bio-Gene Technology Limited, an agtech development company, engages in the development and commercialization of insecticides/pesticides for animal health, crop protection, public health, and consumer applications in Australia. Its lead products include Flavocide, a synthetically produced nature-identical compound; and Qcide, a natural oil extracted from a cultivar of eucalyptus cloeziana. The company has a research collaboration agreement with James Cook University to refine the process for oil extraction; and with BASF, Grains Research and Development Corporation, and Queensland Department of Agriculture and Fisheries for testing of Flavocide in grain storage. Bio-Gene Technology Limited was incorporated in 1995 and is based in Melbourne, Australia.
Bio-Gene Technology Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.